Mitochondrial oxygenation monitoring and acute kidney injury risk in cardiac surgery: A prospective cohort study

被引:0
作者
de Wijs, Calvin J. [1 ]
Streng, Lucia W. J. M. [1 ]
Stolker, Robert Jan [1 ]
ter Horst, Maarten [1 ]
Hoorn, Ewout J. [2 ]
Mahtab, Edris A. F. [3 ]
Mik, Egbert G. [1 ]
Harms, Floor A. [1 ]
机构
[1] Erasmus MC, Dept Anesthesiol, Lab Expt Anesthesiol, Rotterdam, Netherlands
[2] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands
[3] Erasmus MC, Dept Cardiothorac Surg, Rotterdam, Netherlands
关键词
Acute kidney injury; Mitochondrial oxygenation; Cardiac surgery; Coronary artery bypass grafting; CELL TRANSFUSION; PO2; TENSION; ANEMIA;
D O I
10.1016/j.jclinane.2024.111715
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common complication of cardiac surgery and is associated with increased morbidity and mortality. Recent guidelines emphasize the need for new monitoring methods to facilitate targeted CSA-AKI prevention and treatment strategies. In vivo real-time measurement of mitochondrial oxygen tension (mitoPO(2)), could potentially fulfil this role during cardiac surgery, as suggested in our previous pilot study. Methods: In this prospective observational study, we investigated 75 cardiac surgery patients with an increased preoperative CSA-AKI risk. The primary aim of this study was to assess whether patients who developed CSA-AKI experienced prolonged periods of mitoPO(2) < 20 mmHg during surgery. mitoPO(2) was measured intraoperatively, and CSA-AKI was defined according to the Kidney Disease: Improving Global Outcomes criteria. Four additional mitoPO(2) thresholds (<25, <30, <35, and < 40 mmHg) were analyzed, including the predictive capacity of all thresholds for CSA-AKI. Results: This study found that patients who developed CSA-AKI had a significantly longer intraoperative time with mitoPO(2) <20 mmHg and <25, <30, <35, and <40 mmHg. Subsequently, we tested all thresholds for their association with the risk of CSA-AKI, with the <25 mmHg threshold demonstrating the highest significant odds ratio. Every minute spent below <25 mmHg increased the risk of CSA-AKI by 0.7 % (P = 0.021). Conclusions: This study highlighted the association between mitoPO(2) and the onset of CSA-AKI. Extended durations below the mitoPO(2) threshold of 25 mmHg significantly correlate with an elevated CSA-AKI risk. Using mitoPO(2) as a monitoring tool shows promise in potentially predicting and possibly preventing CSA-AKI when used as a treatment trigger in cardiac surgery patients.
引用
收藏
页数:8
相关论文
共 35 条
  • [1] Wang Y., Bellomo R., Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment, Nat Rev Nephrol, 13, pp. 697-711, (2017)
  • [2] Mao H., Katz N., Ariyanon W., Blanca-Martos L., Adybelli Z., Giuliani A., Et al., Cardiac surgery-associated acute kidney injury, Blood Purif, 37, pp. 34-50, (2014)
  • [3] Ortega-Loubon C., Fernandez-Molina M., Carrascal-Hinojal Y., Fulquet-Carreras E., Cardiac surgery-associated acute kidney injury, Ann Card Anaesth, 19, pp. 687-698, (2016)
  • [4] Haines R.W., Powell-Tuck J., Leonard H., Crichton S., Ostermann M., Long-term kidney function of patients discharged from hospital after an intensive care admission: observational cohort study, Sci Rep, 11, (2021)
  • [5] Brown J.R., Baker R.A., Shore-Lesserson L., Fox A.A., Mongero L.B., Lobdell K.W., Et al., The Society of Thoracic Surgeons/Society of Cardiovascular Anesthesiologists/American Society for Extracorporeal Technology Clinical Practice Guidelines for the prevention of adult cardiac surgery-associated acute kidney injury, Anesth Analg, 136, pp. 176-184, (2023)
  • [6] Ostermann M., Kunst G., Baker E., Weerapolchai K., Lumlertgul N., Cardiac surgery associated AKI prevention strategies and medical treatment for CSA-AKI, J Clin Med, (2021)
  • [7] Harms F.A., Stolker R.J., Mik E.G., Correction: cutaneous respirometry as novel technique to monitor mitochondrial function: a feasibility study in healthy volunteers, PloS One, 11, (2016)
  • [8] Neu C., Baumbach P., Plooij A.K., Skitek K., Gotze J., von Loeffelholz C., Et al., Non-invasive assessment of mitochondrial oxygen Metabolism in the critically ill patient using the Protoporphyrin IX-triplet state lifetime technique-a feasibility study, Front Immunol, 11, (2020)
  • [9] Costerus S.A., Bettink M.W., Tibboel D., de Graaff J.C., Mik E.G., Mitochondrial oxygen monitoring during surgical repair of congenital diaphragmatic hernia or esophageal atresia: a feasibility study, Front Pediatr, 8, (2020)
  • [10] Harms F.A., Ubbink R., de Wijs C.J., Ligtenberg M.P., Ter Horst M., Mik E.G., Mitochondrial oxygenation during cardiopulmonary bypass: a pilot study, Front Med, 9, (2022)